Click here for Pharmalot's discussion of the Army's re-opening of its investigation to address the appropriateness of military and civilian physicians receiving compensation from pharmaceutical and device manufactures. The Army Surgeon General initiated this investigation while the Novo Nordisk qui tam case was under seal. Now that the case has been settled, it's time for the Army to look at the command climate that was created that permitted these relationships between industry and military officers. Stay tuned to see whether the Army brass will make scapegoats out of the good men and women who fell in line with what leadership was doing and pushing their subordinates to do. The comments to Pharmalot's article are interesting.